Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Physical fitness, walking performance, and gait in multiple sclerosis.
Risk factors for idiopathic optic neuritis recurrence.
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
Purification of Mouse Brain Vessels.
Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
Multiple sclerosis in Sistan and Baloochestan, South East Iran.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
[Cognitive impairment in multiple sclerosis].
Multiple sclerosis genetics.
Multiple sclerosis and pregnancy.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
The prevalence of urinary catheterization in women and men with multiple sclerosis.
Neuroimaging of dementia.
Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Epigenetic changes in inflammatory and autoimmune diseases.
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Pages
« first
‹ previous
…
390
391
392
393
394
395
396
397
398
…
next ›
last »
